Advances in experimental medicine and biology

publication venue for

Novel Medical Therapies in Meningiomas.. 1416. 2023
Coordination of Mucosal Immunity by Innate Lymphoid Cells.. 1365. 2022
Answering the Challenge of COVID-19 Pandemic Through Innovation and Ingenuity.. 1318. 2021
Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.. 1350. 2021
Interacting Genetic Lesions of Melanoma in the Tumor Microenvironment: Defining a Viable Therapy.. 1350. 2021
Regulation of Human Spermatogenesis.. 1288. 2021
Testicular Torsion and Spermatogenesis.. 1288. 2021
Isolation of Glioma-Initiating Cells for Biological Study.. 899. 2016
Atypical presentation and novel star protein gene mutation in a 46,XY female with lipoid congenital adrenal hyperplasia.. 707. 2011
Clitoroplasty in congenital adrenal hyperplasia: description of technique.. 707. 2011
Standardizing the next generation of bioinformatics software development with BioHDF (HDF5).. 680. 2010
Isothermal titration calorimetry and inhibition of platelets aggregation by [D-Phe/(transcinnamoyl)-Pro-D-Arg-P1'-CONH2] peptides inhibitors of thrombin.. 611. 2009
Identification and validation of the anaplastic large cell lymphoma signature.. 604. 2007
Complex aphthosis: evaluation for Behçet's disease?. 528. 2003
Signaling pathways for TNFa-induced COX-2 expression: mediation through MAP kinases and NFkB, and inhibition by certain nonsteroidal anti-inflammatory drugs.. 507. 2002
Demyelination determinants in the S gene of MHV.. 494. 2001
Differential expression of tumor necrosis factor in primary glial cell cultures infected with demyelinating and non-demyelinating MHVs.. 494. 2001
Mutation of the immunodominant CD8+ epitope in the MHV-4 spike protein.. 494. 2001
Pathogenesis of fusion deficient recombinant mouse hepatitis viruses.. 494. 2001
Programmed cell death in MHV-induced demyelination.. 494. 2001
Role of the spike protein in murine coronavirus induced hepatitis: an in vivo study using targeted RNA recombination.. 494. 2001
The effect of the T1087N S gene mutation on MHV-A59 pathogenesis.. 494. 2001
The role of B cells in mouse hepatitis virus infection and pathology.. 494. 2001
Coronavirus MHV-A59 causes upregulation of interferon-beta RNA in primary glial cell cultures.. 440. 1998
Efficient retroviral infection of human cells utilising an adenoviral vector expressing the ecotropic receptor.. 451. 1998
Targeted recombination between MHV-2 and MHV-A59 to study neurotropic determinants of MHV.. 440. 1998
Taurine chloramine inhibits the production of superoxide anion, IL-6 and IL-8 in activated human polymorphonuclear leukocytes.. 442. 1998
The C12 mutant of MHV-A59 is very weakly demyelinating and has five amino acid substitutions restricted to the spike and replicase genes.. 440. 1998
The pathogenesis of MHV nucleocapsid gene chimeric viruses.. 440. 1998
Growth and differentiation of human dendritic cells from CD34+ progenitors.. 417. 1997
Understanding the structural aspects of neuronal nitric oxide synthase (NOS) using microdissection by molecular cloning techniques: molecular dissection of neuronal NOS.. 387. 1996
Expression of cell adhesion molecules in the fetal gut.. 371A. 1995
Fragmentation and rearrangement of the Golgi apparatus during MHV infection of L-2 cells.. 380. 1995
Genomic regions associated with neurotropism identified in MHV by RNA-RNA recombination.. 380. 1995
Hepatitis mutants of mouse hepatitis virus strain A59.. 380. 1995
Pathology of MHV-A59 infection in beta 2 microglobulin negative mice.. 380. 1995
Progenitor recruitment and in vitro expansion of immunostimulatory dendritic cells from human CD34+ bone marrow cells by c-kit-ligand, GM-CSF, and TNF alpha.. 378. 1995
The protective role of cytotoxic T cells and interferon against coronavirus invasion of the brain.. 380. 1995
Results from a phase I clinical trial of HBED.. 356. 1994
Inducible nitric oxide synthase activity in hepatocytes is dependent on the coinduction of tetrahydrobiopterin synthesis.. 338. 1993
Alpha-mediated vasoconstriction: transmembrane signalling and receptor reclassification.. 311. 1992
Role of guanylate cyclase activation in the smooth muscle actions of dihydropyridines.. 311. 1992
The effects of changes in pO2 on endothelium-dependent and -independent relaxations of the human umbilical artery and rat aorta.. 311. 1992
Treatment of hemorrhagic hypotension with hypertonic saline/dextran: effects on brain surface oxygen tension in experimentally traumatized brain.. 317. 1992
Protection of neonatal mice from fatal reovirus infection by immune serum and gut derived lymphocytes.. 310. 1991
Structure and metabolism of low density lipoproteins from normal and hypertriglyceridemic subjects.. 285. 1991
Dissection of the molecular events occurring during T cell cycle progression.. 213. 1987
Expression of MHC class I genes in mouse hepatitis virus (MHV-A59) infection and in multiple sclerosis.. 218. 1987
The early mitogenic pathway in mouse thymocytes: an analysis of the dual signal hypothesis.. 213. 1987
The rabbit progesterone receptor and uteroglobin gene expression.. 230. 1987
Characterization of hydroxyurea (HYU) resistant S49 T lymphoma cells.. 195 Pt B. 1986
Effects of kinins on the isolated perfused rat kidney and evidence for the presence of renal B1 receptors.. 198 Pt A. 1986
The effect of phosphonoformic acid on wild type and mutant S49 cell lines.. 195 Pt B. 1986
Control of myosin isozymes during myogenesis in the rat.. 182. 1985
Cytotoxic effector mechanisms in AIDS.. 187. 1985
Functional relationships of Lyt-2 and Lyt-3 expression and T-cell cytotoxicity: a new model system.. 184. 1985
Hypertriglyceridemia: lipoprotein receptors and atherosclerosis.. 183. 1985
Influences of testosterone on contractile proteins of the guinea pig temporalis muscle.. 182. 1985
Longitudinal assessment of persistent generalized lymphadenopathy (PGL) in homosexual men.. 187. 1985
The role of hydrophobicity in the structure of the human plasma lipoproteins.. 183. 1985
Detection of MHV-A59 RNA by in situ hybridization.. 173. 1984
MHV-A59 pathogenesis in mice.. 173. 1984
Lymphokine stimulated macrophages inhibit intracellular Chlamydia psittaci replication by mechanisms distinct from intracellular inhibition of Toxoplasma gondii replication.. 162. 1983
Macrophage oxygen-dependent killing of intracellular parasites: Toxoplasma and Leishmania.. 162. 1983
Changes in surface markers of human monocytes following their in vitro maturation to macrophages.. 155. 1982
Abnormal regulation of purine metabolism in a cultured mouse T-cell lymphoma mutant partially deficient in adenylosuccinate synthetase.. 122A. 1980
Changes in blood-brain transfer parameters induced by hyperosmolar intracarotid infusion and by metastatic tumor growth.. 131. 1980
Higher leukocyte nadirs with lithium carbonate after chemotherapy.. 127. 1980
Correlation of biochemical and immunological markers with conventional morphology and clinical features in 120 patients with malignant lymphomas.. 114. 1979
The plasma lipoproteins: current concepts of metabolism and structure with clinical implications.. 104. 1978
The thrombotic process in atherogenesis. Summary of workshop a: endothelium.. 104. 1978
Alcohol, sleep and cerebrospinal fluid changes in alcoholics: cyclic AMP and biogenic amine metabolites in CSF.. 85A. 1977
Electron microscopic techniques in the study of cultured vascular cells.. 82. 1977
Purification and characterization of hypoxanthine-guanine phosphoribosyl transferase from cultured HTC cells.. 76A. 1977
Apo-lipoprotein localization in human atherosclerotic arteries.. 67. 1976
The removal of cellular lipids from Landschůtz ascites cells and smooth muscle cells in culture.. 67. 1976
Experimental ethanol ingestion: sleep variables and metabolites of dopamine and serotonin in the cerebrospinal fluid.. 59. 1975
The interaction of apolipoprotein-alanine (apoC-III) with lipids: study of structural features required for binding.. 63. 1975
Sphingolipid Metabolism and Signaling in Endothelial Cell Functions. 2022
Current Treatment Modalities Targeting Tumor Microenvironment in Castration-Resistant Prostate Cancer. 2021
CRL4 Ubiquitin Pathway and DNA Damage Response. 2020
Chaperome Networks - Redundancy and Implications for Cancer Treatment. 2020
Endometrial Carcinoma and its Precursors. 2020
Endometriosis and Endometriosis-Associated Ovarian Cancer (EAOC). 2020
Heparanase-The Message Comes in Different Flavors. 2020
Thrombospondin in Tumor Microenvironment. 2020
Aging Biomarkers and Novel Targets for Anti-Aging Interventions. 2019
Cytochrome P450 Eicosanoid Signaling Pathway in Colorectal Tumorigenesis. 2019
Emerging Novel Therapeutics in Triple-Negative Breast Cancer. 2019
Regulation of Tau Homeostasis and Toxicity by Acetylation. 2019
Aging Kidney and Aging-Related Disease. 2018
Mesenchymal Stem Cells as Endogenous Regulators of Inflammation. 2018
Minimal Residual Disease in Acute Myeloid Leukemia. 2018
Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease. 2018
Stromal Cells in the Tumor Microenvironment. 2018
MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome. 2017
Mitochondrial Function in Non-ischemic Heart Failure. 2017
Replication Through Repetitive DNA Elements and Their Role in Human Diseases. 2017
Stressors in Atopic Dermatitis. 2017
Epithelial Mesenchymal Transition in Aggressive Lung Cancers. 2016
Genomic Biomarkers for Breast Cancer Risk. 2016
Hypoxic Adaptation in the Nervous System: Promise for Novel Therapeutics for Acute and Chronic Neurodegeneration. 2016
KRAS-Mutant Lung Cancers in the Era of Targeted Therapy. 2016
Noncoding RNAs Regulating Cancer Signaling Network. 2016
Regulation of Interleukin-12 Production in Antigen-Presenting Cells. 2016
Regulation of Interleukin-17 Production. 2016
The Immunobiology of Interleukin-35 and Its Regulation and Gene Expression. 2016
The Microenvironment of Lung Cancer and Therapeutic Implications. 2016
Uncharted Waters: Zebrafish Cancer Models Navigate a Course for Oncogene Discovery. 2016
Molecular Biology of Glucocorticoid Signaling. 2015
Cancer secretomes and their place in supplementing other hallmarks of cancer. 2014
Characterizing multi-omic data in systems biology. 2014
How the dynamic properties and functional mechanisms of GPCRs are modulated by their coupling to the membrane environment. 2014
Muramyl tripeptide-phosphatidyl ethanolamine encapsulated in liposomes (L-MTP-PE) in the treatment of osteosarcoma. 2014
The future of probiotics for disorders of the brain-gut axis. 2014
Immunotherapies in CLL. 2013
Vita-PAMPs: signatures of microbial viability. 2013
Options for fertility preservation in men and boys with cancer. 2012
The contribution of rare diseases to understanding the epidemiology of neurodevelopmental disabilities. 2010
Clinical development of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors: what lessons have we learned? 2008
Targeting mTOR for cancer treatment. 2006
Immunotherapy via dendritic cells. 2005
Using imaging data in making orthopedic diagnoses. 2005
Development of the epidermal growth factor receptor inhibitor Tarceva (OSI-774). 2003
5alpha-reductase-2 deficiency and complete androgen insensitivity: lessons from nature. 2002
Bcl-6 uncouples B lymphocyte proliferation from differentiation. 2002
Traffic patterns of B cells and plasma cells. 2002
Functional role of epitope spreading in the chronic pathogenesis of autoimmune and virus-induced demyelinating diseases. 2001
Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22. 1998
Cell surface dynamics of GPI-anchored proteins. 1997
Left ventricular hypertrophy, arterial compliance, and aging. 1997
Relations of left ventricular geometry and function to prognosis in hypertension. 1997
CD4+ and CD8+ T lymphocyte activation in HIV infection. Implications for immune pathogenesis and therapy. 1995
Immunoglobulin heavy chain variable region gene usage in human autoimmune diseases. 1995
Signal transduction in atherosclerosis: second messengers and regulation of cellular cholesterol trafficking. 1995
Tetrahydrobiopterin synthesis is induced by LPS in vascular smooth muscle and is rate-limiting for nitric oxide production. 1993
Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors. 1992
Role of eicosanoids and the cytokine network in transmembrane signaling in vascular cells. 1991
Arterial cell interactions: mechanistic studies related to eicosanoid and growth factor-induced alterations in cholesterol metabolism. 1988
Control of spontaneous lipid and protein transport. 1988
DARPP-32 as a marker for D-1 dopaminoceptive cells in the rat brain: prenatal development and presence in glial elements (tanycytes) in the basal hypothalamus. 1988
Dopamine-regulated protein phosphorylation in the basal ganglia. 1988
Macrophage activation in the acquired immunodeficiency syndrome. 1988
Endosome acidification and the pathways of receptor-mediated endocytosis. 1987
A molecular basis of activation of the alternative pathway of human complement. 1979
Plasma lipoproteins: recent developments. 1977

VIVO Weill Cornell Medical College

Advances in experimental medicine and biology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)